EUVIMEDEUVIMED entdecken
Validierungsstudie

External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high‐grade prostate cancer patients

Nawar Touma iD, Maxence Larose, Jade Ouellet, Daphnée Bédard-Tremblay, Narcisse Singbo, Hélène Hovington, Bertrand Neveu, Louis Archambault, Frédéric Pouliot

The Prostate · 2024

DOI: 10.1002/pros.24742 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift The Prostate, 2024. Verfasst von Nawar Touma und 8 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Québec-Université Laval Research Center, Université Laval, Quebec City, Canada. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Nomograms, Prostatectomy, Lymphatic Metastasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Commonly used preoperative nomograms predicting clinical and pathological outcomes in prostate cancer (PCa) patients have not been yet validated in high‐grade only PCa patients. Our objective is to perform an external validation of the Memorial Sloan Kettering Cancer Center (MSKCC) preoperative nomogram as a predictor of lymph node invasion (LNI) in a cohort of high‐grade PCa patients.

Methods

We included patients with high‐grade PCa (Gleason ≥8) treated at our institution between 2011 and 2020 with radical prostatectomy and pelvic lymph node dissection without receiving neoadjuvant or adjuvant therapy. The area under the curve (AUC) of the receiver operator characteristic (ROC) was used to quantify the accuracy of the model to predict LNI. A calibration plot was used to evaluate the model's precision, and a decision curve analysis was computed to evaluate the net benefit associated with its use. This study was approved by our institution's ethics board.

Results

A total of 242 patients with a median age of 66 (60−71) years were included. LNI was observed in 70 (29%) patients with a mean of 16 (median = 15; range = 2−42) resected nodes. The MSKCC nomogram discriminative accuracy, as evaluated by the AUC‐ROC was 79.0% (CI: [0.727−0.853]).

Conclusion

The MSKCC preoperative nomogram is a good predictor of LNI and a useful tool associated with net clinical benefit in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsNomogramsProstatectomyLymphatic MetastasisHumansMaleMiddle AgedAgedLymph Node ExcisionLymph NodesNeoplasm GradingCohort StudiesRetrospective Studies

Stichwörter der Autor:innen

Memorial Sloan Kettering Cancer Center (MSKCC) nomogramlymph node invasionoutcomes predictionprostate cancer

Autor:innen und Institutionen

  • CHU de Québec-Université Laval Research Center, Université Laval, Quebec City, Canada.
  • Department of Physics and Optical Engineering, Cancer Research Center, Université Laval, Quebec City, Canada.
  • Faculty of Medicine, Université Laval, Quebec City, Canada.

ORCID-Profile: Nawar Touma

Zitieren

APA

Touma, N., Larose, M., Ouellet, J., Bédard-Tremblay, D., Singbo, N., Hovington, H., Neveu, B., Archambault, L., & Pouliot, F. (2024). External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high‐grade prostate cancer patients. The Prostate. https://doi.org/10.1002/pros.24742

Vancouver

Touma N, Larose M, Ouellet J, Bédard-Tremblay D, Singbo N, Hovington H, et al. External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high‐grade prostate cancer patients. The Prostate. 2024. doi:10.1002/pros.24742

BibTeX
@article{Touma2024,
  author = {Touma, Nawar and Larose, Maxence and Ouellet, Jade and Bédard-Tremblay, Daphnée and Singbo, Narcisse and Hovington, Hélène and Neveu, Bertrand and Archambault, Louis and Pouliot, Frédéric},
  title = {External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high‐grade prostate cancer patients},
  journal = {The Prostate},
  year = {2024},
  doi = {10.1002/pros.24742}
}
Kostenlos starten →